Aug 11, 2026 07:18AM
Jul 29, 2026 06:53AM
Jul 15, 2026 07:39AM
Jul 1, 2026 04:53AM
May 15, 2026 05:07AM
May 12, 2026 04:02PM
May 12, 2026 07:03AM Prelude Therapeutics Incorporated (PRLD) Tops Q1 EPS by 10c
May 4, 2026 07:19AM
Apr 28, 2026 06:42AM
Apr 20, 2026 06:31AM
Mar 11, 2026 05:43AM
Feb 4, 2026 04:50AM
Feb 3, 2026 09:00AM
Dec 8, 2025 04:35AM Prelude Therapeutics' (PRLD) 'Shares A Unique Investment Opportunity' - Citizens
Dec 8, 2025 02:54AM
Nov 14, 2025 06:11AM
Nov 4, 2025 07:05AM
Nov 4, 2025 07:01AM
Sep 23, 2025 06:40AM
Aug 14, 2025 04:22PM
Apr 29, 2025 04:49AM Citizens JMP Reiterates Market Outperform Rating on Prelude Therapeutics (PRLD)
Apr 21, 2025 04:24AM
Mar 12, 2025 06:20AM
Dec 11, 2024 07:30AM
Nov 7, 2024 09:11AM
Oct 9, 2024 07:31AM
Sep 19, 2024 07:04AM
Sep 13, 2024 10:00AM Prelude Therapeutics Inc. (PRLD) Reports SMARCA2 Degrader PRT3789 Demonstrated Promising Initial Clinical Activity and Safety Profile in Phase 1 Trial
Sep 10, 2024 06:43AM
Sep 9, 2024 07:33AM
Aug 12, 2024 09:05AM
Jul 9, 2024 07:31AM
Jun 20, 2024 03:40AM

456,363 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All